Drugs that contain Simeprevir Sodium

1. List of Olysio drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7671032 JANSSEN PRODS HCV NS-3 serine protease inhibitors
May, 2025

(1 year, 11 months from now)

US8349869 JANSSEN PRODS Macrocylic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US8754106 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US8741926 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US9856265 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US9040562 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US8148399 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Sep, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9623022 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

US9353103 JANSSEN PRODS Macrocyclic inhibitors of hepatitis C virus
Jul, 2026

(3 years from now)

Do you want to check out OLYSIO patents from before 2022?

Market Authorisation Date: 22 November, 2013

Treatment: Method of treating hepatitis c

Dosage: CAPSULE;ORAL

More Information on Dosage

OLYSIO family patents

15

United States

9

European Union

5

Sweden

5

Japan

5

Argentina

5

China

4

Korea, Republic of

4

Denmark

4

Spain

4

Poland

4

Hong Kong

3

Ecuador

3

Australia

EA

3

EA

3

Israel

3

Croatia

3

Canada

3

New Zealand

3

Malaysia

3

Costa Rica

3

Austria

3

Cyprus

3

Portugal

3

Ukraine

3

Norway

3

Germany

3

Slovenia

3

RS

3

South Africa

3

Brazil

3

Taiwan

2

Luxembourg

2

Nicaragua

2

ME

2

Hungary

AP

1

AP

1

El Salvador

1

Netherlands

1

Honduras

1

Uruguay

1

Peru

1

Singapore

1

Guatemala

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in